Home » Topics » BioWorld Science

BioWorld Science
RSS

Side effects of botulinum toxin A in the treatment of craniocervical dystonias

Sep. 13, 1996

Rhodanines for multiple sclerosis

Sep. 13, 1996

New treatment strategy for Parkinson's disease introduced

Sep. 13, 1996

New formulation of selegiline

Sep. 13, 1996

Dopaminergic agents claimed by Sandoz

Sep. 13, 1996

ImmunoTherapeutics name change

Sep. 13, 1996

Stryker acquires Osteo

Sep. 13, 1996

Proposed acquisition agreement between Genzyme and Neozyme II

Sep. 13, 1996

Hybridon enters research collaborations for antisense therapies

Sep. 13, 1996

Sugen and ArQule drug discovery collaboration

Sep. 13, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 14, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...